Φορτώνει......
The Risk for Anemia with Targeted Therapies for Solid Tumors
BACKGROUND. Anemia is a common manifestation in patients with cancer. Little is known about the frequency of and risk for anemia with targeted therapies used to treat solid tumors. METHODS. We performed a meta-analysis of randomized controlled trials of solid tumors by comparing targeted therapy (al...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
AlphaMed Press
2012
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3360911/ https://ncbi.nlm.nih.gov/pubmed/22531357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0024 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|